SMN2 and proximal spinal muscular atrophy: Interestingly, ASOs and other therapeutic approaches that treat SMA by augmenting SMN expression, including chief amongst others viral-mediated SMN gene delivery, and orally bioavailable small molecules that correct SMN2 splicing, are not the obvious sequel to basic knowledge gained on SMN function.